Merck to lay off 163 workers in Pennsylvania; Delpharm gets $60M from Canadian government news2025-03-20T16:01:54+00:00March 20th, 2025|Endpoints News|
WuXi AppTec’s US revenue growth continues to dip in post-Biosecure environmentnews2025-03-17T18:34:26+00:00March 17th, 2025|Endpoints News|
Recipharm hits record revenue, eyes GLP-1 deals for growth news2025-03-14T17:07:23+00:00March 14th, 2025|Endpoints News|
Sutro slashes workforce in half, changes CEO and closes factorynews2025-03-14T12:32:54+00:00March 14th, 2025|Endpoints News|
Canada pitches in to Entos’ facility build; Vetter expands in Germanynews2025-03-13T14:26:16+00:00March 13th, 2025|Endpoints News|
Viking Therapeutics taps CordenPharma to manufacture its obesity drugsnews2025-03-12T13:43:22+00:00March 12th, 2025|Endpoints News|
Legend to double Carvykti production as it targets blockbuster status news2025-03-12T11:19:37+00:00March 12th, 2025|Endpoints News|
Corrected: Merck opens billion-dollar US facility to make Gardasilnews2025-03-11T13:50:06+00:00March 11th, 2025|Endpoints News|
Emergent sells once-troubled Baltimore site to Syngenenews2025-03-10T16:17:37+00:00March 10th, 2025|Endpoints News|
CordenPharma’s €100M investment top-up; Cytiva to lay off 85 staffersnews2025-03-06T16:41:12+00:00March 6th, 2025|Endpoints News|
